# Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%

> **NCT02236403** · PHASE3 · COMPLETED · sponsor: **Universidad Nacional de Colombia** · enrollment: 60 (actual)

## Conditions studied

- Chronic Blepharitis

## Interventions

- **DRUG:** Ivermectin 0.1% Metronidazole 1%
- **OTHER:** None intervention

## Key facts

- **NCT ID:** NCT02236403
- **Lead sponsor:** Universidad Nacional de Colombia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236403, "Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02236403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*